Clinical Trial Update: Study of Nasal Insulin to Fight Forgetfulness - Device Study [Phase 2]

View source ↗

Summary

Phase 2 study evaluating intranasal insulin delivered via a device for mild cognitive impairment and cognitive impairment has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Nasal insulin (insulin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Mild Cognitive Impairment, Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2025-08-20